Neuroprotection With Phenytoin in Optic Neuritis

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

March 31, 2015

Conditions
Optic NeuritisMultiple Sclerosis
Interventions
DRUG

Phenytoin

Phenytoin will be loaded using at total dose of 15mg/kg (rounded to the nearest 100mg) divided into three equal doses given once daily for 3 days.This will be followed by a daily maintenance dose of 4mg/kg once a day (rounded up to the nearest 50mg, with a maximum dose of 300mg)for 13 weeks.Phenytoin levels will be taken at 1 and 3 months.

DRUG

Placebo

placebo identical in appearance to active IMP (phenytoin)

Trial Locations (2)

WC1 3BG

National Hospital for Neurology and Neurosurgery, London

Unknown

Royal Hallamshire Hospital, Sheffield

All Listed Sponsors
collaborator

National Multiple Sclerosis Society

OTHER

collaborator

Multiple Sclerosis Society of Great Britain and Northern Ireland

UNKNOWN

lead

University College, London

OTHER

NCT01451593 - Neuroprotection With Phenytoin in Optic Neuritis | Biotech Hunter | Biotech Hunter